Jacobs Levy Equity Management, Inc Vanda Pharmaceuticals Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 165,993 shares of VNDA stock, worth $715,429. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165,993
Previous 274,293
39.48%
Holding current value
$715,429
Previous $1.26 Million
37.81%
% of portfolio
0.0%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding VNDA
# of Institutions
151Shares Held
45.4MCall Options Held
20KPut Options Held
1M-
Black Rock Inc. New York, NY8.14MShares$35.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$15.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$14.9 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$13.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$11.1 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $244M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...